PMID- 35014917 OWN - NLM STAT- MEDLINE DCOM- 20220329 LR - 20220430 IS - 1360-0567 (Electronic) IS - 0963-8237 (Linking) VI - 31 IP - 2 DP - 2022 Apr TI - Clinical and personal recovery for people with schizophrenia in China: prevalence and predictors. PG - 263-272 LID - 10.1080/09638237.2021.2022635 [doi] AB - BACKGROUND: Recovery from schizophrenia is a multidimensional construct that includes two categories: clinical recovery (symptomatic and functional remission) and personal recovery. AIMS: To investigate the overlap between clinical and personal recovery and identify correlates of each. METHODS: A cross-sectional study was conducted with 356 people living with schizophrenia and randomly selected from 12 communities in China. Clinical recovery was assessed using both the Brief Psychiatric Rating Scale (BPRS) and the Global Assessment of Functioning (GAF). Personal recovery was assessed using the 8-item Recovery Assessment Scale (RAS). Disability and quality of life were assessed using the WHODAS 2.0 and WHOQOL-BREF-2, respectively. RESULTS: Our results showed a recovery proportion of 36.52% for clinical recovery (66.57% for symptomatic remission and 40.73% for functional remission), and 17.42% for personal recovery. Only 8.99% of individuals achieved overall recovery (i.e. they met criteria for both clinical and personal recovery), and there was only a modest correlation (r = 0.26) between these two types of recovery. Overall recovery was only correlated with the quality of life (OR = 1.46, 95% CI: 1.05, 2.03), but there were various correlates for clinical recovery and personal recovery separately. CONCLUSIONS: Recovery from schizophrenia involves both clinical and personal recovery, but when examined in the same sample, personal recovery, and thus overall recovery, is less common, particularly among people with schizophrenia in China. FAU - Yu, Yu AU - Yu Y AUID- ORCID: 0000-0001-7657-720X AD - Division of Prevention and Community Research, Yale School of Medicine, New Haven, CT, USA. FAU - Zhou, Wei AU - Zhou W AD - School of Public Administration, Hunan University, Changsha, Hunan, China. FAU - Shen, Minxue AU - Shen M AUID- ORCID: 0000-0003-0441-9303 AD - Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan, China. FAU - Wang, Yao AU - Wang Y AD - Department of Midwifery, Xiangya School of Nursing, Central South University, Changsha, Hunan, China. FAU - Xiao, Shuiyuan AU - Xiao S AD - Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan, China. FAU - Tebes, Jacob Kraemer AU - Tebes JK AD - Division of Prevention and Community Research, Yale School of Medicine, New Haven, CT, USA. LA - eng PT - Journal Article DEP - 20220111 PL - England TA - J Ment Health JT - Journal of mental health (Abingdon, England) JID - 9212352 SB - IM MH - China/epidemiology MH - Cross-Sectional Studies MH - Humans MH - Prevalence MH - Quality of Life/psychology MH - *Schizophrenia/epidemiology/therapy OTO - NOTNLM OT - China OT - Clinical recovery OT - personal recovery OT - quality of life OT - schizophrenia EDAT- 2022/01/12 06:00 MHDA- 2022/03/30 06:00 CRDT- 2022/01/11 12:17 PHST- 2022/01/12 06:00 [pubmed] PHST- 2022/03/30 06:00 [medline] PHST- 2022/01/11 12:17 [entrez] AID - 10.1080/09638237.2021.2022635 [doi] PST - ppublish SO - J Ment Health. 2022 Apr;31(2):263-272. doi: 10.1080/09638237.2021.2022635. Epub 2022 Jan 11.